Synthetic molecular sensors based on CRISPR‐Cas9 redirect anticancer signal flows to treat retinoblastomas
Saved in:
Main Authors: | Lulu Xiao, Jun Li, Yiyu Sheng, Ye Wang, Xiaoyan Dou |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/52b8cf5214eb4f0a94e163021afb711d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC
by: Deborah Y. Kwon, et al.
Published: (2017) -
CRISPR/Cas9 in Gastrointestinal Malignancies
by: André Jefremow, et al.
Published: (2021) -
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
by: Francis P. Pankowicz, et al.
Published: (2016) -
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
by: Chen Dong, et al.
Published: (2018) -
Chromosome drives via CRISPR-Cas9 in yeast
by: Hui Xu, et al.
Published: (2020)